hydroxyindoleacetic acid has been researched along with Binge Eating in 8 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Brofaromine or placebo were administered to female bulimia nervosa patients over a period of eight weeks." | 9.07 | The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa. ( Boulton, AA; D'Souza, J; Davis, BA; Durden, DA; Goldbloom, DS; Kennedy, SH, 1993) |
| " Brofaromine or placebo were administered to female bulimia nervosa patients over a period of eight weeks." | 5.07 | The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa. ( Boulton, AA; D'Souza, J; Davis, BA; Durden, DA; Goldbloom, DS; Kennedy, SH, 1993) |
| " Cerebrospinal fluid levels of L-tryptophan, quinolinic acid, kynurenic acid, L-kynurenine, and 5-hydroxyindoleacetic acid were measured in medication-free female patients meeting DSM-III-R criteria for either anorexia nervosa (n = 10) or normal-weight bulimia nervosa (n = 22), studied at varying stages of nutritional recovery." | 3.69 | Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable. ( Altemus, M; Demitrack, MA; Gold, PW; Heyes, MP; Pigott, TA, 1995) |
| " In this study, we examined cerebrospinal fluid levels of the major monoamine metabolites and beta-endorphin in patients with eating disorders (11 with anorexia nervosa, 16 with bulimia nervosa), while they were acutely ill." | 3.68 | Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot study. ( Altemus, M; Demitrack, MA; Gold, PW; Krahn, DD; Pigott, TA; Putnam, FW; Rubinow, DR, 1993) |
| " In comparison with healthy controls (N = 17), hospitalized bulimic patients with a history of binge eating more frequently than twice daily (N = 11) had significantly lower CSF concentrations of 5-hydroxyindoleacetic acid and homovanillic acid." | 3.68 | Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. ( Brewerton, TD; Jimerson, DC; Kaye, WH; Lesem, MD, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandler-Laney, PC | 1 |
| Castañeda, E | 1 |
| Viana, JB | 1 |
| Oswald, KD | 1 |
| Maldonado, CR | 1 |
| Boggiano, MM | 1 |
| Davis, BA | 2 |
| Kennedy, SH | 2 |
| Durden, DA | 1 |
| D'Souza, J | 2 |
| Goldbloom, DS | 1 |
| Boulton, AA | 1 |
| Brown, GM | 1 |
| Ford, CG | 1 |
| Demitrack, MA | 2 |
| Putnam, FW | 1 |
| Rubinow, DR | 1 |
| Pigott, TA | 2 |
| Altemus, M | 2 |
| Krahn, DD | 1 |
| Gold, PW | 2 |
| Heyes, MP | 1 |
| Kaye, WH | 3 |
| Greeno, CG | 1 |
| Moss, H | 1 |
| Fernstrom, J | 1 |
| Fernstrom, M | 1 |
| Lilenfeld, LR | 1 |
| Weltzin, TE | 1 |
| Mann, JJ | 1 |
| Jimerson, DC | 1 |
| Lesem, MD | 1 |
| Brewerton, TD | 1 |
| Ballenger, JC | 1 |
| Lydiard, RB | 1 |
| Stuart, GW | 1 |
| Laraia, MT | 1 |
| O'Neil, P | 1 |
| Fossey, MD | 1 |
| Stevens, V | 1 |
| Lesser, S | 1 |
| Hsu, G | 1 |
2 trials available for hydroxyindoleacetic acid and Binge Eating
| Article | Year |
|---|---|
The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa.
Topics: Biogenic Amines; Bulimia; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1993 |
Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.
Topics: Adolescent; Adult; Biogenic Amines; Bulimia; Female; Homovanillic Acid; Humans; Hydrogen-Ion Concent | 1993 |
6 other studies available for hydroxyindoleacetic acid and Binge Eating
| Article | Year |
|---|---|
A history of human-like dieting alters serotonergic control of feeding and neurochemical balance in a rat model of binge-eating.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Brain; Bulimia; D | 2007 |
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot study.
Topics: Adolescent; Adult; Anorexia Nervosa; beta-Endorphin; Body Weight; Brain; Bulimia; Dissociative Disor | 1993 |
Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
Topics: Adolescent; Adult; Anorexia Nervosa; Body Weight; Brain; Bulimia; Female; Humans; Hydroxyindoleaceti | 1995 |
Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.
Topics: Adolescent; Adult; Affect; Body Weight; Brain Chemistry; Bulimia; Feeding Behavior; Female; Follow-U | 1998 |
Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes.
Topics: Adult; Body Weight; Bulimia; Dopamine; Eating; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1992 |
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity.
Topics: Adult; Biogenic Monoamines; Bulimia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ne | 1990 |